Kleidox Therapeutics Ltd

Proposed for strike-off12998606 Private limited company
Incorporated
5 November 2020 (6 years)
Industry
Research and experimental development on biotechnology (72110)
Accounts type
Dormant
Region
South East
Address
Hayakawa Building
Edmund Halley Road
Oxford
OX4 4GB

Filing status

Accounts due
31 March 2027
Last accounts
30 June 2025
Conf. stmt due
18 November 2026
Last conf. stmt
4 November 2025

Officers

This list may be incomplete. See all officers on Companies House

Officer details are public data from the Companies House register.

Director · Appointed 30 December 2025
British
Born January 1975 (51)
Officer history (9 former)
3 July 2026
Resigned Walker, Christopher Paul as Director
30 December 2025
Resigned Mackinnon, Alastair Graham as Director
30 December 2025
Appointed Walker, Christopher Paul as Director
30 December 2025
Appointed Abberley, Russell James as Director
30 December 2025
Resigned Smith, Emma as Director
9 February 2024
Resigned Dixon-Clegg, Nicholas George as Director
9 February 2024
Resigned Hanke, Thomas, Dr as Director
9 February 2024
Appointed Mackinnon, Alastair Graham as Director
9 February 2024
Appointed Smith, Emma as Director
18 June 2022
Resigned Stephens, Benedict Charles as Director
18 June 2022
Appointed Hanke, Thomas, Dr as Director
18 June 2022
Appointed Dixon-Clegg, Nicholas George as Director
18 June 2022
Resigned Takenoshita, Takashi as Director
31 December 2021
Resigned Gullerova, Monika, Dr as Director
21 May 2021
Appointed Stephens, Benedict Charles as Director
21 May 2021
Resigned Smith, Emma as Director
18 December 2020
Appointed Gullerova, Monika, Dr as Director
5 November 2020
Appointed Smith, Emma as Director
5 November 2020
Appointed Takenoshita, Takashi as Director

Ownership 1 active

People and entities with significant control, from the Companies House PSC register

Corporate entity · Notified 5 November 2020
Owns 75–100% of shares
Holds 75–100% of voting rights
Right to appoint and remove directors
Private Company Limited By Shares
Reg. no. 12645831

Group structure 4 companies

Ownership group derived from the Companies House PSC register

Dark Blue Therapeutics Ltd Owns 75–100% of shares
Kleidox Therapeutics Ltd This company Proposed for strike-offOwns 75–100% of shares
Sandymount Therapeutics Ltd Owns 75–100% of shares

Financials

Balance sheet as at 30 June 2025 · dormant accounts · dormant

Net Assets
£1

Trend

Net Assets
£0 £1 2021 2023 2024 2025 £1 £1 £1 £1
Balance sheet detail
2025202420232021
Current Assets£0£1
Creditors (< 1 year)£0£5,315
Net Current Assets£0£1
Net Assets£1£1£1£1
Shareholder Funds£1£1£1£1

Filings

Recent filings only. See the full history on Companies House

Some other companies at this address

Other companies in this industry

By trade and location

New companies in Oxford →

Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →

← Back to companies Official record on Companies House ↗

Already have an account?

Create your account

Save searches and get the weekly email of new matches.

First name is required.
Last name is required.
Enter an email address like name@example.com.
Must be at least 8 characters. Password must be at least 8 characters.

Already have an account?